Sheila Oren

Biography

"Dr. Oren has 20 years of international pharma experience, mainly at Teva Pharmaceuticals, where she served as Medical Director. She was responsible for the clinical development and marketing of innovative drugs in CNS and specifically in Parkinson’s disease. Dr. Oren has served as VP Clinical and Regulatory Affairs since September 2008. She also serves as a member of the investment committee and advisory board of New Generation Technology (NGT), a technology incubator, and as a director of MedWell Laboratories Ltd. Dr. Oren holds an MD from the Sackler School of Medicine, Tel Aviv University and an MBA from the Interdisciplinary Center, Herzliya."

Research Interest

clinical development and marketing of innovative drugs in CNS and specifically in Parkinson’s disease.